Business Context and Reporting Period
This Form 8-K is a current report filed by SELLAS Life Sciences Group, Inc. on July 18, 2019, covering events as of July 17, 2019. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "SLS".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial statements.
Material Changes
Item 8.01 (Other Events) discloses that as of July 17, 2019, the company had 225,992,587 shares of common stock outstanding. No other material changes to financial position or operations are detailed in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total number of outstanding shares (225,992,587) as of July 17, 2019.
- Confirm the trading symbol (SLS) and exchange (Nasdaq Capital Market).
- Review subsequent filings for financial performance data not included in this 8-K.